Cargando…

Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors

Beta amyloid peptide is widely studied due to its association with Alzheimer disease (AD). Various study reported that the accumulation of beta amyloid in brain cells leads to Alzheimer disease. Hence, Beta amyloid peptide could be a potential target of anti-AD therapy. Hence, it is of interest to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Aloufi, Bandar, Alshammari, Ahmad Mohajja, Alshammari, Nawaf, Alam, Mohammad Jahoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259223/
https://www.ncbi.nlm.nih.gov/pubmed/37313055
http://dx.doi.org/10.6026/97320630018622
_version_ 1785057619561414656
author Aloufi, Bandar
Alshammari, Ahmad Mohajja
Alshammari, Nawaf
Alam, Mohammad Jahoor
author_facet Aloufi, Bandar
Alshammari, Ahmad Mohajja
Alshammari, Nawaf
Alam, Mohammad Jahoor
author_sort Aloufi, Bandar
collection PubMed
description Beta amyloid peptide is widely studied due to its association with Alzheimer disease (AD). Various study reported that the accumulation of beta amyloid in brain cells leads to Alzheimer disease. Hence, Beta amyloid peptide could be a potential target of anti-AD therapy. Hence, it is of interest to develop potent inhibitors for Beta amyloid peptide in the context of Alzheimer disease (AD). We report the binding features of Ascorbic acid, Cysteine, Dithioerythriol, Dithiothreitol, Malic acid and α-Tocopherol with beta amyloid having binding energy values of -6.7, -6.5, -6.0, -6.5, -6.7 and - 7.0 kcal/mol respectively. The molecular docking of top-scoring compounds with beta amyloid suggests that amino acids such as ASP23, GLU22, Phe19, are crucial in binding. Molecular dynamics simulation study showed steady-state interaction of compounds with beta amyloid for further consideration.
format Online
Article
Text
id pubmed-10259223
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-102592232023-06-13 Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors Aloufi, Bandar Alshammari, Ahmad Mohajja Alshammari, Nawaf Alam, Mohammad Jahoor Bioinformation Research Article Beta amyloid peptide is widely studied due to its association with Alzheimer disease (AD). Various study reported that the accumulation of beta amyloid in brain cells leads to Alzheimer disease. Hence, Beta amyloid peptide could be a potential target of anti-AD therapy. Hence, it is of interest to develop potent inhibitors for Beta amyloid peptide in the context of Alzheimer disease (AD). We report the binding features of Ascorbic acid, Cysteine, Dithioerythriol, Dithiothreitol, Malic acid and α-Tocopherol with beta amyloid having binding energy values of -6.7, -6.5, -6.0, -6.5, -6.7 and - 7.0 kcal/mol respectively. The molecular docking of top-scoring compounds with beta amyloid suggests that amino acids such as ASP23, GLU22, Phe19, are crucial in binding. Molecular dynamics simulation study showed steady-state interaction of compounds with beta amyloid for further consideration. Biomedical Informatics 2022-07-31 /pmc/articles/PMC10259223/ /pubmed/37313055 http://dx.doi.org/10.6026/97320630018622 Text en © 2022 Biomedical Informatics https://creativecommons.org/licenses/by/3.0/This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
spellingShingle Research Article
Aloufi, Bandar
Alshammari, Ahmad Mohajja
Alshammari, Nawaf
Alam, Mohammad Jahoor
Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
title Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
title_full Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
title_fullStr Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
title_full_unstemmed Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
title_short Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
title_sort molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259223/
https://www.ncbi.nlm.nih.gov/pubmed/37313055
http://dx.doi.org/10.6026/97320630018622
work_keys_str_mv AT aloufibandar moleculardynamicssimulationanalysisofthebetaamyloidpeptidewithdockedinhibitors
AT alshammariahmadmohajja moleculardynamicssimulationanalysisofthebetaamyloidpeptidewithdockedinhibitors
AT alshammarinawaf moleculardynamicssimulationanalysisofthebetaamyloidpeptidewithdockedinhibitors
AT alammohammadjahoor moleculardynamicssimulationanalysisofthebetaamyloidpeptidewithdockedinhibitors